Xiangming Yan
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Epigenetics and DNA Methylation 2
- Cell death mechanisms and regulation 2
-
- Cancer, Hypoxia, and Metabolism 3
- MicroRNA in disease regulation 1
- Co-authors
- Qianwei Xiong (11 shared papers)Néstor Rosales (1 shared paper)Carol Aghajanian (1 shared paper)Amreen Husain (1 shared paper)G. K. Schwartz (1 shared paper)Fang Guo (3 shared papers)David R. Spriggs (1 shared paper)Xu Cao (4 shared papers)
- Journals
- Clinical Cancer Research (1 paper)Frontiers in Pediatrics (1 paper)Redox Report (1 paper)Cell Death and Disease (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Xiangming Yan
18 papers receiving 355 citations
Peers
Comparison fields: 5 of 76
- Cancer Research 94
- Applied Microbiology and Biotechnology 10
- Oncology 89
- Molecular Biology 209
- Critical Care and Intensive Care Medicine 12
Countries citing papers authored by Xiangming Yan
This map shows the geographic impact of Xiangming Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangming Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangming Yan more than expected).
Fields of papers citing papers by Xiangming Yan
This network shows the impact of papers produced by Xiangming Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangming Yan. The network helps show where Xiangming Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiangming Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 59 | |
| 2 | UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum(II)independent of p53 status. | 1997 | 48 |
| 3 | 2023 | 43 | |
| 4 | 2023 | 32 | |
| 5 | 2021 | 29 | |
| 6 | 2015 | 28 | |
| 7 | 2017 | 27 | |
| 8 | 2016 | 15 | |
| 9 | 2022 | 13 | |
| 10 | 2024 | 12 | |
| 11 | 2021 | 12 | |
| 12 | 2016 | 10 | |
| 13 | 2024 | 9 | |
| 14 | 2023 | 8 | |
| 15 | 2023 | 5 | |
| 16 | 2024 | 4 | |
| 17 | 2024 | 1 | |
| 18 | Long Non-Coding RNA CRNDE Functions as a Tumor Promoter by Modulating the ERK/MAPK Signaling Pathway in Neuroblastoma Cells. | 2022 | 1 |
| 19 | 2023 | 0 | |
| 20 | 2024 | 0 |
About Xiangming Yan
Xiangming Yan is a scholar working on Molecular Biology, Cancer Research, Genetics, Infectious Diseases and Surgery, having authored 21 papers that have together received 356 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (3 papers), Acute Kidney Injury Research (2 papers), Epigenetics and DNA Methylation (2 papers), Neuroblastoma Research and Treatments (2 papers), Glioma Diagnosis and Treatment (2 papers), Cell death mechanisms and regulation (2 papers), Peptidase Inhibition and Analysis (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Cancer Research (94 citations), Applied Microbiology and Biotechnology (10 citations), Oncology (89 citations), Molecular Biology (209 citations) and Critical Care and Intensive Care Medicine (12 citations). Xiangming Yan has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Qianwei Xiong, Néstor Rosales, Carol Aghajanian, Amreen Husain, G. K. Schwartz, Fang Guo, David R. Spriggs, Xu Cao, Shizhong Cai and Ching‐Hsien Chen. Their work appears in journals such as Clinical Cancer Research, Frontiers in Pediatrics, Redox Report, Cell Death and Disease and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.